|
Post by buyitonsale on May 22, 2021 13:18:49 GMT -5
|
|
|
Post by mytakeonit on May 22, 2021 14:15:25 GMT -5
peppy - see the "9" waving That's me ... But, that's mytakeonit
|
|
|
Post by mytakeonit on May 22, 2021 15:59:06 GMT -5
Finally got to listen to the conference call ... I especially liked hearing about India and current developments.
But, that's mytakeonit
|
|
|
Post by peppy on May 24, 2021 5:34:52 GMT -5
MNKD nasdaq real time volume, 1,374,791 shares. MNKD Nasdaq summary volume, 2,025,051 shares. Avg. Volume 5,104,720 $4.24. -0.07 (-1.62%) At close: 4:00PM EDT NLS Volume 2,091,709
the number of real time shares traded Friday changed to NLS Volume 2,091,709
|
|
|
Post by prcgorman2 on May 24, 2021 6:03:16 GMT -5
The volume would appear to have dropped back to a little higher daily average than what was the case prior to the institutional adds that drove the stock price to where it is and increased the volume average to 5M+ trades. The clock is ticking on the next material changes. If/when those material-ize, I suspect volume will pick up again. GLTALs
|
|
|
Post by uvula on May 24, 2021 9:07:34 GMT -5
"No vaccine manufacture has come to MNKD looking to produce a technosphere vaccine."
Were those MC's exact words? Sounds kind of passive.
Martine would have been actively pursuing the vaccine developers.
|
|
|
Post by goyocafe on May 24, 2021 9:20:32 GMT -5
"No vaccine manufacture has come to MNKD looking to produce a technosphere vaccine." Were those MC's exact words? Sounds kind of passive. Martine would have been actively pursuing the vaccine developers. He’s waiting by his fireplace; they know how to find him.
|
|
|
Post by akemp3000 on May 24, 2021 10:35:02 GMT -5
IMO it would be a big mistake for a small developing drug company that is finally on decent financial footing and has a promising pipeline to follow the masses and chase an elusive and unknown TS vaccine. Sure, it's worth a few phone calls which probably did happen, but it's not worth expensive manhours for what could easily become a new funding burden without a good ROI.
|
|
|
Post by uvula on May 24, 2021 12:50:01 GMT -5
I agree mnkd shouldn't try to develop a vaccine, but if a vaccine developer needed an inhalation device they would pay for everything not mnkd. The vaccine developer just needs to know that mnkd exists.
|
|
|
Post by hellodolly on May 24, 2021 14:17:52 GMT -5
I agree mnkd shouldn't try to develop a vaccine, but if a vaccine developer needed an inhalation device they would pay for everything not mnkd. The vaccine developer just needs to know that mnkd exists. Exactly, and these CEO's most with a lengthy background in the biotechnology/life sciences space (many with doctorates) for 10,15,20 years probably never thought of inhalation of drugs as a delivery mechanism? Strange what's not taught in upper level life sciences courses these days. Heck, maybe they do know but forgot how to do a GOOG search? I don't know, just saying...
|
|
|
Post by mytakeonit on May 24, 2021 14:25:52 GMT -5
Catch phrase has always been ... "Think outside the box"
But, that's mytakeonit
|
|
|
Post by peppy on May 24, 2021 15:06:08 GMT -5
MNKD Nasdaq real time volume, 1,239,881 shares. MNKD Nasdaq summary volume, 1,871,848 Avg. Volume 5,051,025
$4.24. .0000 (0.00%) At close: 4:00PM EDT
|
|
|
Post by peppy on May 25, 2021 16:12:32 GMT -5
MNKD Nasdaq real time volume, 1,589,323 MNKD Nasdaq summary volume, 2,324,815 Avg. Volume 4,973,741
$4.10. -0.14 (-3.30%) At close: 4:00PM EDT
|
|
|
Post by peppy on May 26, 2021 5:00:21 GMT -5
I have been looking at the MNKD Monthly. I had to point out to myself the difference this time. When MNKD hit $6.96 in 2017, It sold off immediately that month. MNKD share price has been trading in that range for what will be 4 months. (look left) A consolidation. Monday is May 31, Memorial Day. The trading month ends on Friday.
|
|
|
Post by peppy on May 26, 2021 8:34:29 GMT -5
MNKD has up volume out of the gate. let's see if it keeps up. we know the numbers, $4.21, $4.33.
|
|